The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Substance Abuse Treatment-Global Market Insights and Sales Trends 2024

Substance Abuse Treatment-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1854391

No of Pages : 100

Synopsis
Substance abuse has become a major cause of concern. People are increasingly getting addicted to a variety of drugs, affecting their health and their family life to a large extent. With prolonged drug and alcohol abuse, the prevalence of mental illness and various chronic diseases, such as diabetes and cardiovascular disorders, have increased substantially among consumers, creating a high economic burden on the nation.
The global Substance Abuse Treatment market size is expected to reach US$ 27740 million by 2029, growing at a CAGR of 6.4% from 2023 to 2029. The market is mainly driven by the significant applications of Substance Abuse Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Substance Abuse Treatment market. Alcohol Abuse Treatment, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nicotine Abuse Treatment segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Substance Abuse Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Substance Abuse Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Substance Abuse Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Substance Abuse Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Substance Abuse Treatment covered in this report include Alkermes, Allergan, GSK, Pfizer, Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx and Cipla, etc.
The global Substance Abuse Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alkermes
Allergan
GSK
Pfizer
Accord Healthcare
Amphastar Pharmaceuticals
Apotex
BioCorRx
Cipla
Glenmark
Global Substance Abuse Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Substance Abuse Treatment market, Segment by Type:
Alcohol Abuse Treatment
Nicotine Abuse Treatment
Drug Abuse Treatment
Global Substance Abuse Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Substance Abuse Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Substance Abuse Treatment
1.1 Substance Abuse Treatment Market Overview
1.1.1 Substance Abuse Treatment Product Scope
1.1.2 Substance Abuse Treatment Market Status and Outlook
1.2 Global Substance Abuse Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Substance Abuse Treatment Market Size by Region (2018-2029)
1.4 Global Substance Abuse Treatment Historic Market Size by Region (2018-2023)
1.5 Global Substance Abuse Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Substance Abuse Treatment Market Size (2018-2029)
1.6.1 North America Substance Abuse Treatment Market Size (2018-2029)
1.6.2 Europe Substance Abuse Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Substance Abuse Treatment Market Size (2018-2029)
1.6.4 Latin America Substance Abuse Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Substance Abuse Treatment Market Size (2018-2029)
2 Substance Abuse Treatment Market by Type
2.1 Introduction
2.1.1 Alcohol Abuse Treatment
2.1.2 Nicotine Abuse Treatment
2.1.3 Drug Abuse Treatment
2.2 Global Substance Abuse Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Substance Abuse Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Substance Abuse Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Substance Abuse Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Substance Abuse Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Substance Abuse Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Substance Abuse Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Substance Abuse Treatment Revenue Breakdown by Type (2018-2029)
3 Substance Abuse Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Substance Abuse Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Substance Abuse Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Substance Abuse Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Substance Abuse Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Substance Abuse Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Substance Abuse Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Substance Abuse Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Substance Abuse Treatment Revenue Breakdown by Application (2018-2029)
4 Substance Abuse Treatment Competition Analysis by Players
4.1 Global Substance Abuse Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Substance Abuse Treatment as of 2022)
4.3 Date of Key Players Enter into Substance Abuse Treatment Market
4.4 Global Top Players Substance Abuse Treatment Headquarters and Area Served
4.5 Key Players Substance Abuse Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Substance Abuse Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Alkermes
5.1.1 Alkermes Profile
5.1.2 Alkermes Main Business
5.1.3 Alkermes Substance Abuse Treatment Products, Services and Solutions
5.1.4 Alkermes Substance Abuse Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Alkermes Recent Developments
5.2 Allergan
5.2.1 Allergan Profile
5.2.2 Allergan Main Business
5.2.3 Allergan Substance Abuse Treatment Products, Services and Solutions
5.2.4 Allergan Substance Abuse Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Allergan Recent Developments
5.3 GSK
5.3.1 GSK Profile
5.3.2 GSK Main Business
5.3.3 GSK Substance Abuse Treatment Products, Services and Solutions
5.3.4 GSK Substance Abuse Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Substance Abuse Treatment Products, Services and Solutions
5.4.4 Pfizer Substance Abuse Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Accord Healthcare
5.5.1 Accord Healthcare Profile
5.5.2 Accord Healthcare Main Business
5.5.3 Accord Healthcare Substance Abuse Treatment Products, Services and Solutions
5.5.4 Accord Healthcare Substance Abuse Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Accord Healthcare Recent Developments
5.6 Amphastar Pharmaceuticals
5.6.1 Amphastar Pharmaceuticals Profile
5.6.2 Amphastar Pharmaceuticals Main Business
5.6.3 Amphastar Pharmaceuticals Substance Abuse Treatment Products, Services and Solutions
5.6.4 Amphastar Pharmaceuticals Substance Abuse Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Amphastar Pharmaceuticals Recent Developments
5.7 Apotex
5.7.1 Apotex Profile
5.7.2 Apotex Main Business
5.7.3 Apotex Substance Abuse Treatment Products, Services and Solutions
5.7.4 Apotex Substance Abuse Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Apotex Recent Developments
5.8 BioCorRx
5.8.1 BioCorRx Profile
5.8.2 BioCorRx Main Business
5.8.3 BioCorRx Substance Abuse Treatment Products, Services and Solutions
5.8.4 BioCorRx Substance Abuse Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 BioCorRx Recent Developments
5.9 Cipla
5.9.1 Cipla Profile
5.9.2 Cipla Main Business
5.9.3 Cipla Substance Abuse Treatment Products, Services and Solutions
5.9.4 Cipla Substance Abuse Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Cipla Recent Developments
5.10 Glenmark
5.10.1 Glenmark Profile
5.10.2 Glenmark Main Business
5.10.3 Glenmark Substance Abuse Treatment Products, Services and Solutions
5.10.4 Glenmark Substance Abuse Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Glenmark Recent Developments
6 North America
6.1 North America Substance Abuse Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Substance Abuse Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Substance Abuse Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Substance Abuse Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Substance Abuse Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Substance Abuse Treatment Market Dynamics
11.1 Substance Abuse Treatment Industry Trends
11.2 Substance Abuse Treatment Market Drivers
11.3 Substance Abuse Treatment Market Challenges
11.4 Substance Abuse Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’